vida: extract claims from 2026-04-28-noom-glp1-companion-biomarker-integration-2025

- Source: inbox/queue/2026-04-28-noom-glp1-companion-biomarker-integration-2025.md
- Domain: health
- Claims: 0, Entities: 0
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/health/digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring.md

@@ -46,3 +46,10 @@ Omada's Enhanced GLP-1 Care Track achieved 67% persistence at 12 months versus 4
 **Source:** PHTI December 2025 employer report
 
 34% of employers now mandate behavioral support as a coverage condition (up from 10%), and three major payers (Evernorth, Optum Rx, UHC) have operationalized behavioral support as prerequisite infrastructure. This represents market-wide validation that behavioral support improves persistence enough to justify mandatory implementation at the payer level.
+
+
+## Supporting Evidence
+
+**Source:** Noom 2025 performance data, Pharmaceutical Commerce
+
+Noom's microdose GLP-1Rx users showed 77.8% engagement with the app for 4+ weeks, with December cohort D30 engagement at 43.6% (10x+ higher than average health/medical/fitness app retention of 4.3%). The company identified side effect management as the primary cause of 30%+ dropout in first 4 weeks during titration phase, and addressed this through microdosing strategy (lower dose → fewer side effects → higher adherence) rather than purely behavioral interventions.

domains/health/glp1-behavioral-support-market-stratifies-by-physical-integration-with-atoms-to-bits-companies-profitable-and-behavioral-only-companies-bankrupt.md

@@ -45,3 +45,10 @@ WeightWatchers post-bankruptcy strategy (July 2025) explicitly avoids CGM integr
 **Source:** WW International post-bankruptcy clinical strategy, December 2025
 
 WeightWatchers' post-bankruptcy (May 2025) strategy shows selective CGM deployment: Abbott FreeStyle Libre integration for WW Diabetes Program (6-month RCT showing 0.9 HbA1c reduction, 33.8% depression symptom reduction, 62% physical function increase), but NO CGM integration for general GLP-1/obesity Med+ program. The Med+ program uses only AI body scanner and photo-based food tracking—no physical data generation. This selective deployment suggests WW recognizes the atoms-to-bits moat but constrains it to diabetes where CGM reimbursement is established, not extending to the obesity market where Omada (CGM + behavioral + prescribing, profitable, $260M revenue, IPO June 2025) is winning.
+
+
+## Extending Evidence
+
+**Source:** Noom press releases + Pharmaceutical Commerce, December 2025
+
+Noom's December 2025 'Proactive Health Microdose GLP-1Rx' program ($149/month) combines microdosed GLP-1 with at-home biomarker testing every four months, representing a distinct atoms-to-bits integration strategy from Omada's continuous CGM monitoring. This periodic biomarker testing approach (quarterly) vs. continuous monitoring (daily) represents two different physical-to-digital integration strategies with different cost/adherence tradeoffs. Noom achieved $100M revenue run-rate within four months of launching GLP-1 programs in September 2024, demonstrating that periodic biomarker testing can be commercially viable as a physical integration layer.

domains/internet-finance/prediction-market-platform-competition-decided-by-ownership-alignment-not-product-features.md

@@ -0,0 +1,19 @@
+---
+type: claim
+domain: internet-finance
+description: Hayes argues HYPE token ownership gives Hyperliquid users direct economic stake in platform success, creating evangelism advantage over Polymarket/Kalshi
+confidence: experimental
+source: Arthur Hayes (BitMEX co-founder, Maelstrom CIO), April 30 2026 analysis
+created: 2026-04-30
+title: Prediction market platform competition in 2026 is being decided by ownership alignment rather than product features or regulatory status, with token-value-accrual models constituting a competitive moat that non-ownership user models cannot easily replicate
+agent: rio
+sourced_from: internet-finance/2026-04-30-arthur-hayes-hype-token-prediction-market-ownership-alignment.md
+scope: causal
+sourcer: Arthur Hayes / CoinDesk
+supports: ["ownership-alignment-turns-network-effects-from-extractive-to-generative", "community-ownership-accelerates-growth-through-aligned-evangelism-not-passive-holding"]
+related: ["permissionless-leverage-on-metadao-ecosystem-tokens-catalyzes-trading-volume-and-price-discovery-that-strengthens-governance-by-making-futarchy-markets-more-liquid", "ownership-alignment-turns-network-effects-from-extractive-to-generative", "community-ownership-accelerates-growth-through-aligned-evangelism-not-passive-holding"]
+---
+
+# Prediction market platform competition in 2026 is being decided by ownership alignment rather than product features or regulatory status, with token-value-accrual models constituting a competitive moat that non-ownership user models cannot easily replicate
+
+Arthur Hayes argues that Hyperliquid's HIP-4 prediction market will dominate not because of superior technology, lower fees, or better regulatory positioning, but because HYPE token holders can 'directly profit from platform activity' in a way Polymarket and Kalshi users cannot. This is an ownership alignment thesis applied to platform competition: users with economic stake in HYPE's value accrual become aligned evangelists, while competitors' users remain passive consumers. Hayes explicitly frames HYPE as 'the weapon' rather than the zero-fee structure or Kalshi-designed market infrastructure. The mechanism is that token ownership transforms users from extractive participants into generative network effects drivers. This is testable: if HIP-4 gains market share disproportionate to its product advantages, it would validate ownership alignment as the decisive competitive factor. Hayes's prediction carries weight given his track record building BitMEX (first major crypto perps exchange) and calling HYPE's rise to $38B FDV. The competitive context is stark: Polymarket's premarket POLY token implies ~$14B FDV but users cannot yet capture platform upside; Kalshi is US-regulated with no comparable token; Hyperliquid offers zero fees and Asia-focused distribution while blocking US users. If ownership alignment is the moat Hayes claims, we should see HYPE holders evangelizing HIP-4 more aggressively than Polymarket/Kalshi users evangelize their platforms, creating asymmetric growth despite Polymarket's brand lead and Kalshi's regulatory clarity.

entities/internet-finance/hyperliquid-hip-4.md

@@ -0,0 +1,41 @@
+# Hyperliquid HIP-4
+
+**Type:** Prediction market protocol  
+**Parent:** Hyperliquid  
+**Status:** Testnet (as of April 2026)  
+**Market Design:** Outcome contracts (event-based, settles 0 or 1)  
+**Fee Structure:** Zero-fee  
+**Regulatory Status:** Offshore, blocks US users  
+**Key Partnership:** Kalshi market design expertise  
+
+## Overview
+
+Hyperliquid HIP-4 is a prediction market protocol built on Hyperliquid's infrastructure, using "outcome contracts" that settle to 0 or 1 based on event resolution. The protocol leverages Kalshi's market design expertise while maintaining Hyperliquid's zero-fee structure and offshore positioning.
+
+## Competitive Positioning
+
+Arthur Hayes (BitMEX co-founder, Maelstrom CIO) argued in April 2026 that HIP-4's competitive advantage comes from HYPE token ownership alignment rather than product features. Users who own HYPE can directly profit from platform activity, unlike Polymarket or Kalshi users, creating economic incentive for evangelism.
+
+**Market Context (April 2026):**
+- HYPE market cap: ~$38B FDV
+- Polymarket premarket POLY: ~$14B FDV (not yet launched)
+- Primary audience: Asia-focused (Polymarket faces geoblocking in several Asian countries)
+- US users blocked from Hyperliquid main exchange
+
+## Competitive Dynamics
+
+**vs. Polymarket:**
+- Hyperliquid: zero fees, HYPE token ownership model, Asia distribution
+- Polymarket: established brand, POLY token not yet launched, blocks US users on main exchange
+
+**vs. Kalshi:**
+- Hyperliquid: offshore, zero fees, HYPE token ownership
+- Kalshi: US-regulated, fee-based, no comparable user ownership token
+
+## Timeline
+
+- **2026-04-30** — Arthur Hayes published analysis arguing HIP-4 will dominate prediction markets through HYPE ownership alignment advantage
+
+## Sources
+
+- CoinDesk, "Hyperliquid's HYPE Token Could Be Its Prediction Market Weapon, Arthur Hayes Says", April 30, 2026

inbox/archive/health/2026-04-28-noom-glp1-companion-biomarker-integration-2025.md

@@ -7,10 +7,13 @@ date: 2025-12-01
 domain: health
 secondary_domains: []
 format: news
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-04-30
 priority: medium
 tags: [noom, GLP-1, behavioral-support, biomarker, digital-health, adherence, microdose]
 intake_tier: research-task
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content

inbox/archive/internet-finance/2026-04-30-arthur-hayes-hype-token-prediction-market-ownership-alignment.md

@@ -7,10 +7,13 @@ date: 2026-04-30
 domain: internet-finance
 secondary_domains: []
 format: article
-status: unprocessed
+status: processed
+processed_by: rio
+processed_date: 2026-04-30
 priority: medium
 tags: [hyperliquid, hype-token, prediction-markets, ownership-alignment, polymarket, kalshi, hip-4, arthur-hayes]
 intake_tier: research-task
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content